Physician profile
Brian D Cassetta
NPI 1336116037
$1,016.36
in general payments reported to CMS, 2019-2025
9 companies · $291 in 2025
The $291 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.86 · 2021: $31.10 · 2022: $121 · 2023: $272 · 2024: $260 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $823.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $822.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $485.13 | 2022-2025 | Vraylar |
| Pfizer INC. | $114.71 | 2021-2025 | |
| Novo Nordisk INC | $101.11 | 2024-2025 | Ozempic, Rybelsus |
| Exact Sciences Corporation | $98.79 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Ascensia Diabetes Care US INC. | $73.95 | 2024 | |
| Spr Therapeutics, INC | $67.81 | 2025 | Sprint Pns System |
| Medtronic USA, INC. | $40.86 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $22.29 | 2024 | Airsupra |
| Lilly USA, LLC | $11.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Cassetta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.